Lexpos News

/Lexpos News

Drug Tariff Watch – March 2026

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2026. Part VIIIA – Basic prices of drugs Contractors should note changes made to the notes to Part VIIIA regarding Categories A, C, H and M. [...]

The post Drug Tariff Watch – March 2026 appeared first on Community Pharmacy England.

By |February 25th, 2026|Lexpos News|Comments Off on Drug Tariff Watch – March 2026

PQS reminder: Declaration closes this Friday

Pharmacy owners have until 11.59pm on Friday (27th February 2026) to make their Pharmacy Quality Scheme (PQS) 2025/26 declaration through the MYS portal, as the window for claiming this payment will then close. Pharmacy owners must have evidence to demonstrate meeting the gateway criterion and the domains that they have claimed for by the end of 31st [...]

The post PQS reminder: Declaration closes this Friday appeared first on Community Pharmacy England.

By |February 25th, 2026|Lexpos News|Comments Off on PQS reminder: Declaration closes this Friday

MHRA Drug Safety Update: Falsified Mounjaro KwikPen 15mg pre-filled pens

A falsified version of Mounjaro (tirzepatide) KwikPen 15mg solution for injection has been found supplied through one online pharmacy in the UK. The falsified product is labelled with batch D873576 and applies to Mounjaro KwikPen 15mg solution for injection in pre-filled pen only. The issue was identified due to faults with the pens, where in [...]

The post MHRA Drug Safety Update: Falsified Mounjaro KwikPen 15mg pre-filled pens appeared first on Community Pharmacy England.

By |February 24th, 2026|Lexpos News|Comments Off on MHRA Drug Safety Update: Falsified Mounjaro KwikPen 15mg pre-filled pens

MHRA Class 4 Medicines Defect Notification: Dropodex 0.1% w/v Eye Drops, solution (Rayner Pharmaceuticals Limited)

MHRA Class 4 Medicines Defect Notification: Dropodex 0.1% w/v Eye Drops, solution (Rayner Pharmaceuticals Limited) Drug alert number: EL(26)A/10 Date issued: 24 February 2026 Rayner Pharmaceuticals limited have informed the MHRA that the batches listed in this notification do not include the concentration of phosphates in the product information. DMRC reference number: DMRC-38371734 Marketing Authorisation Holder: Rayner [...]

The post MHRA Class 4 Medicines Defect Notification: Dropodex 0.1% w/v Eye Drops, solution (Rayner Pharmaceuticals Limited) appeared first on Community Pharmacy England.

By |February 24th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Dropodex 0.1% w/v Eye Drops, solution (Rayner Pharmaceuticals Limited)

MHRA Class 2 Medicines Recall: KidNaps (Melatonin) 1mg in 1ml Oral Solution (Sterling Pharmaceuticals Ltd)

MHRA Class 2 Medicines Recall: KidNaps (Melatonin) 1mg in 1ml Oral Solution (Sterling Pharmaceuticals Ltd) Drug alert number: EL(26)A/09 Date issued: 23 February 2026 Sterling Pharmaceuticals Ltd and Veriton Pharma Ltd are recalling all batches of KidNaps (Melatonin) 1mg in 1ml Oral Solution due to out of specification stability results. DMRC reference number: DMRC-38487919 Company name: Sterling [...]

The post MHRA Class 2 Medicines Recall: KidNaps (Melatonin) 1mg in 1ml Oral Solution (Sterling Pharmaceuticals Ltd) appeared first on Community Pharmacy England.

By |February 23rd, 2026|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: KidNaps (Melatonin) 1mg in 1ml Oral Solution (Sterling Pharmaceuticals Ltd)